The ubiquitin proteasome system and its involvement in cell death pathways

被引：32
作者：
Bernassola, F. [1 ]
Ciechanover, A. [2 ,3 ]
Melino, G. [1 ,4 ]
机构：
[1] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Biochem Lab, IDI IRCCS, Rome, Italy
[2] Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31906 Haifa, Israel
[3] Technion Israel Inst Technol, Res Inst, IL-31906 Haifa, Israel
[4] MRC, Toxicol Unit, Leicester, Leics, England
来源：
CELL DEATH AND DIFFERENTIATION | 2010年 / 17卷 / 01期
基金：
英国医学研究理事会;
关键词：
PROTEIN-DEGRADATION; IN-VIVO; INHIBITOR; APOPTOSIS; CANCER; P53; ACTIVATION; BORTEZOMIB; LYSOSOME; COMPLEX;
D O I：
10.1038/cdd.2009.189
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 3
页数：3
相关论文
共 35 条
  • [1] Development of the proteasome inhihitor Veleade™ (Bortezomib)
    Adams, J
    Kauffman, M
    [J]. CANCER INVESTIGATION, 2004, 22 (02) : 304 - 311
  • [2] Dissecting the role of ubiquitylation in the DNA damage response checkpoint in G2
    Bassermann, F.
    Pagano, M.
    [J]. CELL DEATH AND DIFFERENTIATION, 2010, 17 (01) : 78 - 85
  • [3] The role of ubiquitylation for the control of cell death in Drosophila
    Bergmann, A.
    [J]. CELL DEATH AND DIFFERENTIATION, 2010, 17 (01) : 61 - 67
  • [4] The HECT family of E3 ubiquitin ligases: Multiple players in cancer development
    Bernassola, Francesca
    Karin, Michael
    Ciechanover, Aaron
    Melino, Gerry
    [J]. CANCER CELL, 2008, 14 (01) : 10 - 21
  • [5] Identification of the familial cylindromatosis tumour-suppressor gene
    Bignell, GR
    Warren, W
    Seal, S
    Takahashi, M
    Rapley, E
    Barfoot, R
    Green, H
    Brown, C
    Biggs, PJ
    Lakhani, SR
    Jones, C
    Hansen, J
    Blair, E
    Hofmann, B
    Siebert, R
    Turner, G
    Evans, DG
    Schrander-Stumpel, C
    Beemer, FA
    van den Ouweland, A
    Halley, D
    Delpech, B
    Cleveland, MG
    Leigh, I
    Leisti, J
    Rasmussen, S
    Wallace, MR
    Fenske, C
    Banerjee, P
    Oiso, N
    Chaggar, R
    Merrett, S
    Leonard, N
    Huber, M
    Hohl, D
    Chapman, P
    Burn, J
    Swift, S
    Smith, A
    Ashworth, A
    Stratton, MR
    [J]. NATURE GENETICS, 2000, 25 (02) : 160 - 165
  • [6] A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
    Chauhan, D
    Catley, L
    Li, GL
    Podar, K
    Hideshima, T
    Velankar, M
    Mitsiades, C
    Mitsiades, N
    Yasui, H
    Letai, A
    Ovaa, H
    Berkers, C
    Nicholson, B
    Chao, TH
    Neuteboom, STC
    Richardson, P
    Palladino, MA
    Anderson, KC
    [J]. CANCER CELL, 2005, 8 (05) : 407 - 419
  • [7] Proteolysis: from the lysosome to ubiquitin and the proteasome
    Ciechanover, A
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (01) : 79 - 86
  • [8] Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting
    Ciechanover, A
    [J]. CELL DEATH AND DIFFERENTIATION, 2005, 12 (09) : 1178 - 1190
  • [9] Therapeutic strategies within the ubiquitin proteasome system
    Eldridge, A. G.
    O'Brien, T.
    [J]. CELL DEATH AND DIFFERENTIATION, 2010, 17 (01) : 4 - 13
  • [10] XIAP as a ubiquitin ligase in cellular signaling
    Galban, S.
    Duckett, C. S.
    [J]. CELL DEATH AND DIFFERENTIATION, 2010, 17 (01) : 54 - 60
1234